Illana Gozes, PhD
Primary tabs
JAD profile
Associate Editor
Regional Editor
Term Expiration:
12/31/2025
Affiliation(s):
Tel Aviv University
ORCID URL:
Areas of Interest:
aging, Alzheimer's disease, axonal transport, cytoskeleton, gene expression, neurodegeneration, neuropeptides, phosphorylation, tau
Biography & Research:
Professor Emerita Illana Gozes
The Lily and Avraham Gildor Chair for the Investigation of Growth Factors
Head, the Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology
Department of Human Molecular Genetics and Biochemistry
Faculty of Medicine
The Adams Super Center for Brain Studies and Sagol School of Neuroscience,
Tel Aviv University
Israel.
Professor Emerita Illana Gozes, BSc, Tel Aviv University, PhD, Weizmann Institute, Israel, postdoc. MIT and Salk Institute, USA, Senior Scientist/Associate Professor, Weizmann Institute, Fogarty Scholar, NIH, USA, currently, Professor (Emerita) for Clinical Biochemistry at Tel Aviv University (mentoring numerous students). She published ~360 papers in neuroscience and is the inventor of numerous patents including davunetide, a clinical Phase 2-3 drug candidate (founded Allon Therapeutics and currently Chief Scientific Officer at ATED Therapeutics) and ADNP, an essential protein for brain formation implicated in autism, schizophrenia, Alzheimer’s disease and cancer. She won many awards of excellence (including Tel Aviv University’s Vice President Award, Olson Prize, Julodan Prize, Teva Prize, Neufeld Award, Hanse-Wissenschaftskolleg (HWK) fellowship, Humboldt Award, Landau Prize for Life Achievements, 2013). Ex-President of the Israel Society for Neuroscience (honorary member 2020), served on the Governing Committee and Board of Governors of Tel Aviv University and the Council for Higher Education of Israel. and is currently the Editor-in-Chief of the Journal of Molecular Neuroscience and the Secretary of the European Society for Neurochemistry.
Site Participation